LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy

NCT01986777 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding not obtained

Conditions

Cognitive Impairments
RRSO

Interventions

DRUG: lisdexamfetamine
DRUG: Placebo

Sponsor

University of Pennsylvania